FDA approves Lilly's ADHD drug Strattera

FDA approves Lilly's ADHD drug Strattera - FierceBiotech

FDA approves Lilly's ADHD drug Strattera
FierceBiotech, DC - May 8, 2008
Lilly says this is the first regulatory win for a non-stimulant ADHD drug in a market dominated by two stimulants–Adderall (Shire) and Ritalin (Novartis). …

Find Out More:

Books:

Talking Back to Ritalin: What Doctors Aren’t Telling You About Stimulants and ADHD
Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
Concerta Side Effects
Ritalin-Free Kids: Safe and Effective Homeopathic Medicine for ADHD and Other Behavioral and Learning Problems
Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders

May 10th, 2008
Adderall

Truncated Domes

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Natural ADHD Treatments

Discuss the topics raised by this article on the Myomancy Forum.

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism